LYMPHOPROLIFERATIVE DISORDERS
Clinical trials for LYMPHOPROLIFERATIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISORDERS trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could existing cancer drugs work for more rare tumors?
Disease control Not yet recruitingThis study tests whether two approved drugs, dabrafenib and trametinib, can shrink or control rare cancers that have a specific genetic change called BRAF V600. About 30 adults and children with various rare cancers will receive the drug combination. The goal is to see if these d…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Massive study to unravel mysterious Immune-Blood disorder link
Knowledge-focused Not yet recruitingThis study will follow 5,000 adults with immune system problems to see if they also have hidden blood cell mutations (clonal hematopoiesis), including the rare VEXAS syndrome. Researchers aim to track how often these immune issues appear with blood disorders. No new treatments ar…
Matched conditions: LYMPHOPROLIFERATIVE DISORDERS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC